Sex Product Flibanserin CAS 167933-07-5 for Female Sexual Enhancer
Place of Origin | CHINA |
---|---|
Brand Name | XRD |
Certification | GMP |
Model Number | 167933-07-5 |
Minimum Order Quantity | negotiable |
Price | Inquiry for Negotiable |
Packaging Details | 1-2 Kg / Aluminum Foil Bag, 25kg/ Drum, as Require |
Delivery Time | 1-2days after payment received |
Payment Terms | T/T, Western Union,Bitcoin |
Supply Ability | 100kg/year |

Contact me for free samples and coupons.
Whatsapp:0086 18588475571
Wechat: 0086 18588475571
Skype: sales10@aixton.com
If you have any concern, we provide 24-hour online help.
xCas No. | 167933-07-5 | Product Name | Flibanserin |
---|---|---|---|
Usage | Pharmaceutical Raw Material | Appearance | White Powder |
Assay | 99% | Grade | Pharmaceutical Grade |
Storage | Cool Dried Storage | Application | Pharmaceutical Raw Intermediates |
High Light | pharm raw material,raw steroid powders |
Sex Product Flibanserin CAS 167933-07-5 for Female Sexual Enhancer
Detail:
Name: Flibanserin
Chemical formula: C20H21F3N4O
Molecular Weight: 390.4
Assay: 99%
CAS: 167933-07-5
CBNumber: CB91178756
Apperance: white powder
Usage: kind of sex enhancer medicion.
Description:
Flibanserin (INN, USAN), sold under the trade name Addyi, is a medication approved for the treatment of pre-menopausal women with hypoactive sexual desire disorder (HSDD).The medication increases the number of satisfying sexual events per month by about one half to one over placebo from a starting point of about two to three.
HSDD was recognized as a distinct sexual function disorder for more than 30 years, but was removed from the Diagnostic and Statistical Manual of Mental Disorders in 2013, and replaced with a new diagnosis called female sexual interest/arousal disorder (FSIAD).
COA
Items | Specification |
Appearance | white crystals or crystalline powder, has a faint, characteristic odor and bitter taste |
Solubility | freely soluble in water and 95%ethanol, sparingly soluble in acetic anhydride and practically insoluble in diethyl ether |
pH | 3.5-4.5 |
Identification | 1, red to dark purple color appears with(III)iron chloride |
2, light red precipitate formed with reinecke salt TS | |
3, UV spectrum meet the reference | |
4, solution (1%) responds to the qualitative test for chloride | |
Melting point | 139-143 celcius degree |
Clarity and color of solution | clear and colorless |
Sulfate | 0.048%max |
Heavy metals | 10ppm max |
As | 2ppm max |
Organic acid(0.1M NaOH) | 0.54ml max |
Loss on drying | 0.5% max |
Residue on ignition | 0.1%max |
Residual organic Solvents (GC) | Xylol 0.217%max |
Isopropanol 0.5%max | |
Related substances(HPLC) | Total impurity 1.5%max |
Single impurity0.5%max | |
Free P-chloro phenoxy acetic 0.5%max | |
Count of bacteria | bacillus 1000/1g max |
Mildew 100/1g max | |
Microzyme 100/1g max | |
Assay(C12H16CINO3.HCl,on dry basis) | 98%min |
Function:
(1) dizziness
(2) nausea
(3) Tiredness
(4) difficulty falling asleep or staying asleep
(5) dry mouth
Application:
A new drug designed to boost sexual desire in women is controversial for some and eagerly awaited by others, but it's hit a potentially serious snag. The drug didn't boost women's desire any more than a placebo in two clinical trials. The Food and Drug Administration posted the clinical trial results on its website today in advance of a committee meeting on Friday, when a panel of experts will vote whether or not to recommend approval of the drug called flibanserin. (The FDA usually follows the recommendations of its expert panels. ) Although there was a slight increase in the number of sexually satisfying events flibanserin users had each month, the FDA staff who reviewed the results said the so-called response rate isn't "particularly compelling. "
Packing:
Sex Product Flibanserin CAS 167933-07-5 for Female Sexual Enhancer